Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT06446765
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Borderline Personality Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Not accepted
Interventions
- mindfulness-based Neurofeedback — BEHAVIORALParticipants will complete one session of mindfulness-based fMRI neurofeedback prior to 20 weeks of remote online weekly DBT skills group.
- control Neurofeedback — OTHERParticipants will complete one session of control fMRI neurofeedback prior to 20 weeks of remote online weekly DBT skills group.
Study Details
The purpose of this study is to test the ability of mindfulness-based real time functional magnetic resonance imaging (fMRI) neurofeedback (mbNF) to increase the benefits of evidence-based psychotherapy for adults with Borderline Personality Disorder (BPD).
Key Dates
- Start date
- Mar 13, 2025
- Status verified
- Jun 2026
- Primary completion
- Oct 30, 2026
- Completion
- Oct 30, 2026
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: mindfulness-based NeurofeedbackParticipants will participate in one session of mindfulness-based fMRI neurofeedback followed by 20 weeks of remote online weekly Dialectical Behavior Therapy skills group.
- Other: control NeurofeedbackParticipants will participate in one session of control fMRI neurofeedback followed by 20 weeks of remote online weekly Dialectical Behavior Therapy skills group.
Primary Outcome Measure
Change in within-Default Mode Network (DMN) resting state functional connectivity after one session of neurofeedback (NF) [ Time Frame: From baseline (immediately before neurofeedback) to immediately after neurofeedback on the same day ]
Central Contacts
- Sarah K Fineberg, MD PhD203-974-7265
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Connecticut Mental Health Center | New Haven | Connecticut | 06519 |
Find similar trials in New Haven, CT
By research site
Related Studies
- MDMA in Borderline Personality DisorderPHASE2 · Recruiting · Yale University · New Haven, Connecticut
- Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel TherapeuticsRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric PopulationsRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- A Precision Medicine Approach to Target Engagement for Emotion RegulationRecruiting · Matthew Southward, PhD · Columbus, Ohio